International Vaccine Access Center at Johns Hopkins BSPH

Last week, IVAC Assistant Scientist Andrea Carcelen attended the Workshop on Serosurveillance of Infectious Diseases at the National University Toribio Rodríguez de Mendoza de Amazonas in Chachapoyas, Perú. She helped to train partners on the use of multiplex technology for serosurveillance to hopefully expand the use of serosurveillance in Latin American countries. "This powerful surveillance tool allows you to assess dozens of antibodies to infectious diseases from a single drop of blood," Dr. Carcelen explained. Learn more about serosurveillance: https://lnkd.in/eFUS9uXn

How are #rotavirus vaccines making a difference across Africa? ✅ Ghana: 2.2M cases and 8,900 deaths averted ✅ Uganda: $57M saved in diarrhea-related expenses  ✅ Rwanda: 60% reduction in rotavirus hospitalizations Explore the impact in other countries ⤵️ https://lnkd.in/gyMQMU8s

Last night, we were so pleased to award the Albert B. Sabin Gold Medal to the World Health Organization's Dr. Katherine O’Brien, and the Rising Star Award to Dr. Livancliff Mbianke (mbianke livancliff) of Cameroon. 📽️ Watch the ceremony, and hear from both recipients ⤵️ https://lnkd.in/eUPjNF_d 📝 Learn more about these awards and the work of the awardees ⤵️ https://lnkd.in/esQwaSWJ

Over the past 50 years, global immunization efforts have saved 154 million lives – that's equal to 6 lives every minute, every year. This #WorldVaccineDay, we continue to work toward a world free from adverse health, economic, and social consequences of vaccine-preventable diseases.

Malaria has stolen too many futures in Mali. But communities celebrate "a huge step forward" as malaria vaccines begin to roll out in 19 districts across 5 hard hit regions.    With support from health workers, families and religious leaders, on 25 April, Mali launched a groundbreaking vaccine programme designed to protect when it matters most.    Using an innovative approach, children will receive three doses close together, then further doses right before mosquito season. This smart timing could become a model for other countries fighting seasonal malaria.    Read the full story: https://bit.ly/4kethnj

In a recent BioSpace piece, IVAC Executive Director Dr. William Moss explains why inert placebos are not the only suitable controls in vaccine trials. "It is unethical to give children an inert placebo when there already is an established vaccine with demonstrated effectiveness," he said. https://lnkd.in/e95pUkFD Via Heather McKenzie

ICYMI: A recording from last week's webinar, "Measles in America: Causes, Risks, and Responses" is now available! https://lnkd.in/ew4x73_a Featuring: Michael Mina, MD, PhD, Walter Orenstein, and Daniel Salmon Johns Hopkins Bloomberg School of Public Health

"How do we ensure children grow into adults? [By] ensuring that they are vaccinated to prevent diseases." 21 parliamentarians from 10 countries are working together to create a blueprint for sustainable #immunisation financing.

The latest Global Vaccine Introduction and Implementation Report from VIEW-hub is now available! This quarterly report highlights changes to introduction status and use for the 9 vaccines included on VIEW-hub, such as the nationwide introduction of typhoid conjugate vaccine by Burkina Faso in January. Read more: https://lnkd.in/egZVcGA4 Subscribe to our quarterly newsletter to be the first to receive future reports: https://lnkd.in/enefqssU

When #cholera strikes, every hour counts. As cholera resurges globally, the vaccine stockpile's importance grows. From just 2.5 million doses in 2016 to over 37 million in 2024, see how this lifesaving resource is responding to surging outbreaks worldwide.